APA (7th ed.) Citation

E, C., M, P., A, F., M, C., I, C., A, M., & A, C. (2021). Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 35(2), 175. https://doi.org/10.1007/s40259-021-00467-w

Chicago Style (17th ed.) Citation

E, Chessa, Piga M, Floris A, Congia M, Cangemi I, Mathieu A, and Cauli A. "Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 35, no. 2 (2021): 175. https://doi.org/10.1007/s40259-021-00467-w.

MLA (9th ed.) Citation

E, Chessa, et al. "Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 35, no. 2, 2021, p. 175, https://doi.org/10.1007/s40259-021-00467-w.